Table 2. Statistics table of cancer type by mutation in the 833 samples.
Cancer type | Mutation | |||||||
---|---|---|---|---|---|---|---|---|
ALK | BRAF | EGFR | KRAS | PIK3CA | HER2 | OTHERS | Total | |
ADa | ||||||||
Frequency | 1 | 9 | 57 | 198 | 5 | 0 | 287 | 557 |
Expected | 0.67 | 6.02 | 38.78 | 138.41 | 6.69 | 0 | 366.43 | |
Chi-square | 0.16 | 1.48 | 8.56 | 25.66 | 0.43 | 0 | 17.22 | |
SQb | ||||||||
Frequency | 0 | 0 | 1 | 4 | 5 | 0 | 188 | 198 |
Expected | 0.24 | 2.14 | 13.79 | 49.2 | 2.38 | 0 | 130.26 | |
Chi-square | 0.24 | 2.14 | 11.86 | 41.53 | 2.88 | 0 | 25.59 | |
OTHERS | ||||||||
Frequency | 0 | 0 | 0 | 5 | 0 | 0 | 73 | 78 |
Expected | 0.094 | 0.84 | 5.43 | 19.38 | 0.94 | 0 | 51.31 | |
Chi-square | 0.094 | 0.84 | 5.43 | 10.67 | 0.94 | 0 | 9.17 | |
Total | 1 | 9 | 58 | 207 | 10 | 0 | 548 | 833 |
There is strong evidence of an association.
aAdenocarcinoma.
bSquamous cell carcinoma.